Summary
DexCom, Inc. (DXCM) filed an 8-K on October 26, 2023, to announce its financial results for the third quarter ended September 30, 2023. The filing includes a press release detailing the company's performance and other relevant information. While this 8-K is primarily an informational filing and the contents are furnished rather than deemed 'filed' for regulatory purposes, it provides investors with timely updates on the company's operational and financial standing. Investors should refer to the furnished press release for specific details on the quarterly performance, as it contains the primary financial disclosures. This report is crucial for understanding DexCom's recent business trajectory and financial health as it relates to the third quarter of 2023. It serves as a direct communication channel from the company to its shareholders regarding its financial results and operational highlights. Investors seeking a comprehensive understanding of DexCom's performance should carefully review the accompanying press release, which is incorporated by reference into this filing.
Key Highlights
- 1DexCom, Inc. (DXCM) reported its financial results for the third quarter ended September 30, 2023, via an 8-K filing on October 26, 2023.
- 2The 8-K filing incorporates a press release (Exhibit 99.1) containing the detailed financial and operational results for the quarter.
- 3The information provided in the 8-K is furnished and not deemed 'filed' under Section 18 of the Exchange Act, limiting certain liabilities.
- 4This filing serves as a key disclosure for investors to track DexCom's recent performance.
- 5Investors are directed to the furnished press release for the specific details of the Q3 2023 financial results.